Surrey Now-LeaderDrive for stem cell donors in LangleySurrey Now-LeaderMore than 390,000 Canadians have joined the OneMatch Stem Cell and Marrow Network registry maintained by Canadian Blood Services, volunteering to be stem cell donors for any patient… Continue reading
|
Cost-effectiveness of allergen immunotherapy evaluated
Medical Xpress … the researchers found that sublingual immunotherapy (SLIT) and subcutaneous immunotherapy would be considered cost-effective using the U.K. National Institute for Health and Clinical Excellence threshold of £20,000/quality-adjusted life-year (QALY). |
Lymphoma Hub |
CLL post-ibrutinib: CAR T-cell therapy shown to result in durable molecular remissions
Lymphoma Hub Use of anti-CD19 Chimeric Antigen Receptor (CAR) T-cell therapy in CLL previously treated with ibrutinib has recently been shown to induce ‘durable molecular remissions’ in a phase I/II open-label study. The study, published in the Journal of Clinical … |
NewsChannel5.com |
Using your own stem cells to help your body heal osteoarthritis
Medical Xpress It works like this: Stem cells are extracted from a patient with a needle—usually from abdominal fat (adipose tissue) or bone marrow within the hip—and placed into a centrifuge, where the sample is spun rapidly to isolate the stem cells and create a … Stem Cell Therapy can provide a surgery-free solution to knee and …Colorado Springs Gazette Innovative Medical Solutions: Stem Cell TherapyNewsChannel5.com Global Stem Cell Market – Positive long term growth outlook 2016 …Medgadget (blog) Blasting News –The Pharma Letter (registration) –Health Thoroughfare all 14 news articles » |
|
With New Patent, Cesca Eyes Faster, Less Costly CAR–T Cell Production
Genetic Engineering & Biotechnology News Chimeric antigen receptor T–cell receptor (CAR-T) and CAR-modified natural killer (CAR-NK) therapeutics can be produced faster and at less cost, Cesca Therapeutics says, through the cellular processing technology covered by a recently-awarded patent. |